24 Dec, EOD - Indian

SENSEX 78472.87 (-0.09)

Nifty 50 23727.65 (-0.11)

Nifty Bank 51233 (-0.16)

Nifty IT 43668.9 (-0.36)

Nifty Midcap 100 57057.9 (-0.06)

Nifty Next 50 68857.25 (-0.05)

Nifty Pharma 22558.9 (-0.06)

Nifty Smallcap 100 18732.65 (0.24)

24 Dec, EOD - Global

NIKKEI 225 39336.39 (0.53)

HANG SENG 20098.29 (1.08)

S&P 6112.5 (0.04)

Login/Signup
LOGIN HERE
Cancel

Himadri Speciality Chemical Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 500184 | NSE Symbol : HSCL | ISIN : INE019C01026 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
09-Oct-2024 16-Oct-2024 Quarterly Results Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) will be held on Wednesday 16 October 2024 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for quarter and six months ended 30 September 2024. Financial Results for the quarter and six- months ended 30 September 2024 We would like to inform you that the Board at its meeting held today, i.e., on 16 October 2024, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six-months ended 30 September 2024. Read less.. (As Per BSE Announcement Dated on 16.10.2024)
09-Jul-2024 16-Jul-2024 Quarterly Results Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/07/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) will be held on Tuesday the 16 July 2024 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for the quarter ended 30 June 2024. We would like to inform you that the Board at its meeting held on 16.07.2024 inter-alia has considered and approved the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2024. (As Per BSE Announcement dated on 16.07.2024)
18-Apr-2024 25-Apr-2024 Accounts Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) will be held on Thursday 25 April 2024 inter-alia to consider the following: 1. To approve and take on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2024; 2. To recommend payment of Dividend if any Further pursuant to the Code of Conduct to Regulate Monitor and Report Trading by Designated Persons and their immediate relatives under SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in securities of the Company which was closed from 1 April 2024 will reopen 48 hours after the declaration of the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31 March 2024. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we would like to inform you that the Board of the Company at its' meeting held today i.e. on 25 April 2024, inter-alia has considered and approved the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31 March 2024 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we would like to inform you that the Board of the Company at its' meeting held today i.e. on 25 April 2024, inter-alia has considered and approved the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended 31 March 2024 Audited Financial Result (Standalone & Consolidated) for the quarter and year ended 31.03.2024 The Board of Directors at its meeting held on 25.04.2024 inter-alia has re-appointed: 1. Mr. Anurag Choudhary as Chairman cum Managing Director & CEO for a further term of five years w.e.f 14.08.2024 2. Mr. Amit Choudhary as a Whole-time Director for a further term of five years w.e.f 14.08.2024 Read less.. The Board of Directors at its meeting held on 25.04.2024 inter-alia has approved the appointment of Secretarial Auditor and re-appointment of Internal Auditor (As per BSE Announcement Dated on 25/04/2024)
15-Mar-2024 20-Mar-2024 Preferential Issue Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2024 inter alia to consider and approve Notice pursuant to Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (SEBI (LODR) Regulations 2015) is hereby given that a meeting of the Board of Directors (Board) of Himadri Speciality Chemical Ltd (Company) is scheduled to be held on Wednesday the 20 March 2024 inter-alia to consider and approve the following: 1. Proposal for issuance of equity shares by way of preferential allotment in accordance with the applicable law subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company; 2. Proposal for raising of funds by way of issuance of equity shares / preference shares / bonds / debentures / warrants or any other eligible securities through permissible modes including but not limited to Preferential Issue Private Placement Qualified Institutions Placement or any equivalent capital raising mode or combination of methods. Board of Directors of Himadri Speciality Chemical Ltd ('Company') at its meeting held today, i.e., on 20.03.2024 inter-alia has considered and approved the following: 1. Acquisition of 40% equity shares of Invati Creations Private Limited. 2. Issue of Equity Shares of the Company on preferential basis, for consideration other than cash. 3. Preferential issue of warrants. 4. Seeking approval of shareholders for issuance of securities on a preferential basis through Postal Ballot. The Meeting of the Board of Directors commenced at 11.00 a.m. (IST) and concluded at 12:50 p.m. (IST) We request you to kindly take on record the same Pursuant to Regulation 30 of the SEBI(LODR) Regulations, 2015 we would like to inform you that the Board of Directors at its meeting held on 20.03.2024 has inter-alia approved the 1. Issue of equity shares of the Company on preferential basis, for consideration other than cash; 2. Preferential issue of Warrants; (As Per BSE Announcement dated on 20.03.2024)
09-Jan-2024 16-Jan-2024 Quarterly Results Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/01/2024 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Tuesday 16 January 2024 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31 December 2023. We would like to inform you that the Board at its meeting held today i.e on 16.01.2024, inter-alia has considered and approved the unaudited financial results (Standalone and Consolidated) for the quarter and nine months ended 31.12.2023. We would like to inform you that the Board at its' meeting held today i.e., on 16 January 2024, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31 December 2023. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31 December 2023. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31 December 2023. (As Per BSE Announcement Dated on 16/01/2024)
06-Dec-2023 05-Dec-2023 Acquisitions Pursuant to Regulation 30 of SEBI Listing Regulations, this is to inform you that Himadri Clean Energy Limited, the WOS has informed the Company that it has proposed to acquire 100% shareholdings of Himadri Future Material Technology Limited to make it WOS. On completion of above acquisition Himadri Future Material Technology Limited will become a step down WOS of the Company. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), this is to inform you that the Board of Directors of the Company at its' meeting held on 5 December 2023, inter-alia has considered and approved setting up of the Manufacturing facility for the production of Lithium-ion Battery (LiB) components with total annual production capacity of 200,000 MT either directly and/or through its subsidiaries .
10-Oct-2023 17-Oct-2023 Quarterly Results Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2023 inter alia to consider and approve Notice pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Tuesday the 17 October 2023 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2023. We would like to inform you that the Board at its' meeting held today i.e., on 17 October 2023, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six-month period ended 30 September 2023. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and six-month period ended 30 September 2023. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six-month period ended 30 September 2023. Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, this is to inform you that the Board at its meeting held today on 17 October 2023, inter-alia has considered and approved acquisition of 100% equity shares of Himadri Clean Energy Limited. We would like to inform you that the Board of Directors at its meeting held today i.e on 17 October 2023 inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six months period ended 30 September 2023. (As per BSE Announcement Dated on 17/10/2023)
11-Jul-2023 18-Jul-2023 Quarterly Results Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2023 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Tuesday the 18 July 2023 inter-alia to approve and take on record the Un-audited Standalone and Consolidated Financial Results for the quarter ended 30 June 2023. We would like to inform you that the Board of Directors at its meeting held on 18.07.2023, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2023. We are enclosing herewith Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2023 along with Limited Review Report. We request you to kindly take on record the same. We would like to inform you that the Board at its' meeting held today i.e. on 18 July 2023, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2023. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2023. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2023. The Meeting of the Board of Directors commenced at 6.00 p.m (IST) and concluded at 7:15 p.m.(IST) We request you to kindly take on record the same. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors at its meeting held on 18.07.2023, inter-alia has considered and approved acquisition of 100% Equity Shares of Combe Projects Private Limited. (As Per BSE Announcement dated on 18.07.2023)
21-Apr-2023 28-Apr-2023 Accounts Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2023 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Friday the 28 April 2023 inter-alia to consider the following: 1. To approve and take on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2023; 2. To recommend payment of Dividend if any Final Dividend & Audited Results (As per BSE Bulletin dated on 21/04/2023) We are enclosing herewith the following pursuant to Regulation 30 and 33 read with the applicable provisions of Schedule III and IV of the SEBI (LODR) Regulations, 2015: Audited Financial Results i) Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31 March 2023 along with Auditors Report thereon; ii) Statement of Assets and Liabilities (Standalone & Consolidated) for the financial year ended 31 March 2023; iii) Audited Cash Flow Statement (Standalone & Consolidated) for the financial year ended 31 March 2023; iv) Declaration of Managing Director & CEO on Audit Reports with unmodified opinion pursuant to Regulation 33(3) (d) of SEBI (LODR) Regulations, 2015. 2. Declaration of Dividend The Board has recommended to the shareholders a final dividend of Re. 0.25 per equity share of Re 1 each (i.e. 25% of face value of equity share) for the FY 2022-23; The Meeting of the Board of Directors commenced at 5:00 pm and concluded at 7:00 pm. We would like to inform you that the Board at its' meeting held today i.e. on 28 April 2023, inter-alia has considered and approved the following: 1. Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31 March 2023. 2. Declaration of Dividend The Board has recommended to the shareholders a final dividend of Re. 0.25 per equity share of Re 1 each (i.e. 25% of face value of equity share) for the FY 2022-23; Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this to inform you that the Board at its' meeting held on today i.e, on 28 April 2023, inter-alia has recommended to the shareholders a final dividend of Re 0.25 per equity share of Re 1 each (i.e. 25% of face value of equity share) for the Financial Year 2022-23. The above dividend, if declared by the shareholders at the ensuing Annual General Meeting will be credited/ dispatched within 30 days from the date of declaration. The record date for determining entitlement of the members to final dividend shall be intimated in due course. The Meeting of the Board of Directors commenced at 5:00 pm and concluded at 7:00 pm. We request you to kindly take on record the same. (As Per BSE Announcement Dated on 28.04.2023)
03-Feb-2023 10-Feb-2023 Quarterly Results Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Friday the 10 February 2023 inter-alia to approve and take on record the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31 December 2022. We would like to inform you that the Board at its' meeting held today i.e. on 10 February 2023, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31 December 2022. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31 December 2022. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31 December 2022. The Meeting of the Board of Directors commenced at 5.30 p.m and concluded at 6:20 p.m. (As Per BSE Announcement dated on 10.02.2023)
21-Oct-2022 29-Oct-2022 Quarterly Results Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2022 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Saturday the 29 October 2022 inter-alia to approve and take on record the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2022. We would like to inform you that the Board at its' meeting held today i.e. on 29 October 2022, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30 September 2022. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30 September 2022. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six months ended 30 September 2022. The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 5:00 p.m. We would like to inform you that the Board at its' meeting held today i.e. on 29 October 2022, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30 September 2022. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30 September 2022. ii) The Limited Review Report of the Statutory Auditors of the Company, M/s Singhi & Co, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter and six months ended 30 September 2022. The Meeting of the Board of Directors commenced at 12:30 p.m. and concluded at 5:00 p.m. (As Per BSE Announcement Dated on 29.10.2022)
03-Aug-2022 11-Aug-2022 Quarterly Results Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Thursday the 11 August 2022 inter-alia to approve and take on record the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2022. We would like to inform you that the Board at its' meeting held today i.e. on 11 August 2022, inter-alia has considered and approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2022. We are enclosing herewith the following pursuant to Regulation 30 and Regulation 33 read with the applicable provisions of Schedule III and IV of the SEBI (LODR) Regulations, 2015: i) Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2022; ii) The Limited Review Report of the Statutory Auditors of the Company, M/s B S R & Co. LLP, Chartered Accountants on the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30 June 2022. The Meeting of the Board of Directors commenced at 2.30 p.m. and concluded at 7.10 p.m. (As Per BSE Announcement Dated 11.08.2022)
14-Jul-2022 21-Jul-2022 Accounts Himadri Speciality Chemical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2022 inter alia to consider and approve Notice pursuant to Regulation 29 of SEBI (LODR) Regulations 2015 is hereby given that the meeting of the Board of Directors of Himadri Speciality Chemical Ltd will be held at its Corporate Office: Ruby House 8 India Exchange Place 2nd Floor Kolkata - 700 001 on Thursday the 21 July 2022 inter-alia to consider the following: 1. To approve and take on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2022; 2. To recommend payment of Dividend if any Board approved: 1. Appointment of Mr. Anurag Choudhary (DIN: 00173934), Managing Director & CEO as the Chairman of the Board of Directors of the Company 2. The Board has recommended to the shareholders a final dividend of Re. 0.20 per equity share of Re 1 each (i.e. 20% of face value of equity share) for the Financial Year 2021-22. We would like to inform you that the Board at its' meeting held today i.e. on 21st July 2022, inter-alia has considered and approved the following: 1. Appointment of Mr. Anurag Choudhary (DIN: 00173934), Managing Director & CEO as the Chairman of the Board of Directors of the Company: 2. Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31 March 2022. 3. Declaration of Dividend Site optimized for IE9 & above. : Disclaimer : Website Policies : Privacy Policy : Sitemap Copyright c BSE Ltd. All Rights Reserved. We would like to inform you that the Board at its' meeting held today i.e. on 21st July 2022, inter-alia has considered and approved the following: 1. Appointment of Mr. Anurag Choudhary (DIN: 00173934), Managing Director & CEO as the Chairman of the Board of Directors of the Company: This is to inform you that the Board at its' meeting held today i.e., on 21st July 2022, inter-alia has considered and approved the appointment of Mr. Anurag Choudhary (DIN: 00173934), Managing Director & CEO, as the Chairman of the Board of Directors of the Company with immediate effect i.e., effective from today's meeting. 2. Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31 March 2022. 3. Declaration of Dividend The Board has recommended to the shareholders a final dividend of Re. 0.20 per equity share of Re 1 each (i.e. 20% of face value of equity share) for the Financial Year 2021-22; Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), this to inform you that the Board at its' meeting held on today i.e., on 21 July 2022, inter-alia has appointed M/s Singhi & Co, Chartered Accountants (FRN 302049E) as the Statutory Auditors of the Company for a period of 5 (Five) consecutive years from the conclusion of the ensuing 34th Annual General Meeting (AGM) till the conclusion of 39th AGM, subject to approval of the members of the Company at the ensuing AGM, in place of M/s B S R & Co. LLP, Chartered Accountants, whose term is completing at the conclusion of the ensuing 34th AGM of the Company. (As Per BSE Bulletin Dated on 21.07.2022)
11-Jul-2022 14-Jul-2022 Others Inter-alia to consider and evaluate proposal for raising of funds by the Company in one or more tranches through one or more permissible mechanisms as may be deemed appropriate by the Board, by way of issuance of equity shares and / or other securities including share warrants convertible into Equity shares of the Company and / or any other equity based instruments / securities including through preferential issue, private placement, or through any other permissible mode or any combination thereof, subject to receipt of regulatory / statutory / shareholders approvals, as may be requir We would like to inform you that the Board of Directors of the Company at its meeting held today, i.e., on 14 July 2022 inter-alia has considered and approved the following: 1. Preferential issue of warrants: To issue upto 7,25,50,000 warrants each convertible into, or exchangeable for, 1 (one) fully paid up equity share of the Company, having a face value of INR 1/- (Rupee one only) within the period of 18 (eighteen months) in accordance with the applicable laws ('Warrants') at a price of ? 70.00/- (Rupees Seventy only) each (including the warrant subscription price and the warrant exercise price) aggregating upto ? 5,07,85,00,000 (Rupees Five Hundred Seven Crores Eighty Five Lakhs Only) to the Promoter/ Promoter Group of the Company and certain identified non-promoter persons / entity. 2. Convening an Extra Ordinary General Meeting of the Company To hold an Extraordinary General Meeting ('EGM') of the members of the Company on Monday, the 08 August 2022 at 1:00 p.m. (IST). (As Per BSE Announcement Dated 14.07.2022)
09-Jul-2022 08-Jul-2022 Others Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), this to inform you that in the Board Meeting held on July 8, 2022, it was informed to the Board members that the Promoters of the Company have inter-se entered into a Family Settlement Agreement ('FSA') by virtue of which BLC Family (as defined below) have: i. ceased to hold any right in the management and/or control in the Company; ii. have also submitted request / application under Regulation 31A of SEBI Listing Regulations to re-classify themselves from promoter and promoter group to public category; and
1 2